Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04539743
Other study ID # 38RC20.193
Secondary ID 2020-A0156534
Status Recruiting
Phase
First received
Last updated
Start date October 15, 2020
Est. completion date February 2021

Study information

Verified date December 2020
Source University Hospital, Grenoble
Contact Bernard BOILLOT
Phone +33 (0)4 76 76 59 19
Email BBoillot@chu-grenoble.fr
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

The creation of an abdominal continental cystostomy orifice is an irreplaceable surgical technique that allows for the simple self-sounding of the bladder in patients with severe disabilities or malformations, and to obtain urinary continence. This operation, the principle of which was described by Paul Mitrofanoff in 1980, has benefited from countless descriptions, difficult realization and questionable design, so it is insufficiently proposed. Faced with this learning difficulty at the beginning of the year, we decided to define a "step-by-step" technique, in seven well-differentiated steps. This approach has simplified the teaching and dissemination of this technique. To validate its quality, it is necessary to evaluate the expected results of a continental cystostomy, by answering two simple questions: -is the cystostomy opening really continent? Is the cystostomy tube easy to catheterize?


Description:

This research consists in highlighting that the Mitrofanoff surgery technique used by the CHUGA surgeons during a cystostomy is easier to perform while having the necessary same results as the other methods. To do this, we must validate the quality of this method and therefore we will evaluate the results expected from a continuous cystostomy via a questionnaire. After a first telephone contact by Dr BOILLOT for a presentation of the study, patient will therefore be contacted by telephone by the Clinical Research Associate of the service. During this interview patient will be asked to answer a questionnaire consisting of five questions.


Recruitment information / eligibility

Status Recruiting
Enrollment 70
Est. completion date February 2021
Est. primary completion date February 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - adult who has undergone a Mitrofanoff cystostomy by Dr. BOILLOT Exclusion Criteria: - Persons referred to in Articles L1121-5 to L1121-8 of the CSP (corresponds to all protected persons: pregnant women, parturient women, nursing mothers, persons deprived of their liberty by judicial or administrative decision, persons subject to a legal protection measure) - Patients operated on by other surgeons

Study Design


Locations

Country Name City State
France Chu Grenoble Alpes Grenoble

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Grenoble

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary To evaluate, in a series of identically operated patients, the expected results of a continuous cystostomy: -is the cystostomy hole really continental? -is the cystostomy tube easy to catheterize Average of the Scores obtained on the questionnaires carried out 1 month
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04219046 - Evaluation of Naloxegol in the Prevention of POI After Cystectomy Phase 2
Completed NCT05822518 - Outcome of Perioperative Immune Enhancing Nutrition in Patients Undergoing Radical Cystectomy N/A
Recruiting NCT03032822 - Opioid Consumption in Cystectomy Patients